Latest News
FDA accepts Genentech's giredestrant application for early-stage breast cancer
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Application under Priority Review for giredestrant as a...
Ansun Biopharma reports positive recommendation from independent DMC for DAS181
2 June 2026 - Clinical-stage biopharmaceutical company Ansun Biopharma Inc announced on Monday that its independent Data Monitoring Committee (DMC) has issued a positive recommendation following a prespecified interim efficacy and safety review of th...
UCB launches scholarship program for adults living with hidradenitis suppurativa
2 June 2026 - Biopharmaceutical company UCB (EBR:UCB) announced on Monday the launch of the inaugural UCB Hidradenitis Suppurativa Scholarship Program.This program is designed to support adults age 18 and older living with hidradenitis suppurativa (H...
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
2 June 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that it has received marketing authorisation from the European Commission for IMDYLLTRA (tarlatamab) as a monotherapy to treat adults with extensive-stage small cell l...
Heart Rhythm Society partners with Milestone Pharmaceuticals to offer new SVT patient resources
2 June 2026 - The Heart Rhythm Society (HRS) announced on Monday that it has formed a collaboration with Milestone Pharmaceuticals, an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines for certain heart...